|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Aceto Corporation Announces Rising Pharmaceuticals, Inc Subsidiary Launches Generic Version of Soma(R) Compound With Aspirin and Codeine Tablets and Generic Version of Decadron(R) Elixir
4/11/2012 9:57:49 AM
PORT WASHINGTON, N.Y., April 11, 2012 (GLOBE NEWSWIRE) -- Aceto Corporation (Nasdaq:ACET), a global leader in the marketing, sales and distribution of pharmaceutical intermediates and active ingredients, finished dosage form generics, nutraceutical products, agricultural protection products and specialty chemicals, today announced that Rising Pharmaceuticals Inc., its finished dosage form generic subsidiary, has launched the 200mg/325 mg/16 mg strengths of Carisoprodol, Aspirin and Codeine phosphate Tablets USP, an approved generic version of Meda Pharmaceutical's Soma® Compound with Aspirin and Codeine Tablets, and 0.5mg/5ml strength of Dexamethasone Elixir USP, an approved generic version of Merck & Co., Inc's., Decadron® Elixir, following the U.S. Food and Drug Administration (FDA) approval of both Abbreviated New Drug Applications (ANDA). According to IMS Health data, U.S. brand sales for Carisoprodol, Aspirin and Codeine tablets, which is used to relieve pain and muscle spasms, and Dexamethasone Elixir, which is a steroid used to treat severe allergies, arthritis and asthma, were approximately $5.8 Million collectively for the twelve months ended December, 2011.
|
|
|
|
|
|
|
|
|
|
|